Literature DB >> 3354546

Enzyme-linked immunosorbent assays for the detection of class-specific immunoglobulins to Borrelia burgdorferi.

L A Magnarelli1, J F Anderson.   

Abstract

Enzyme-linked immunosorbent assays were developed to detect immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies to Borrelia burgdorferi, the etiologic agent of Lyme disease. Of the 135 blood samples obtained during 1985-1986 from persons in Connecticut with erythema migrans or other clinical manifestations of this spirochetosis, 106 (79%) contained IgM antibody. In separate tests for IgG antibody, 106 (83%) of 128 specimens were considered positive. To assess the specificity of these assays, the authors analyzed sera from patients with other spirochetal infections or nonrelated diseases. Heterologous IgM antibody was detected in 32 (42%) of 77 samples, while cross-reactivity occurred in 17 (25%) of 69 sera screened for IgG antibody. Geometric mean titers for homologous reactions were usually twofold or more higher than those of heterologous reactions. Information on IgG antibody is particularly useful for serodiagnosis, but because of the cross-reactivity among Borrelia and Treponema, clinical data and the use of other serologic tests may be needed to separate Lyme disease from other spirochetal infections.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3354546     DOI: 10.1093/oxfordjournals.aje.a114864

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  24 in total

1.  Laboratory confirmation of Lyme disease.

Authors:  T G Schwan; W J Simpson; P A Rosa
Journal:  Can J Infect Dis       Date:  1991

2.  Intra- and interlaboratory reproducibility of an ELISA serological test for Lyme disease.

Authors:  M C Tammemagi; J W Frank; M Leblanc; H Artsob
Journal:  Can J Infect Dis       Date:  1995-03

3.  Characterization of the protective antibody response to Borrelia burgdorferi in experimentally infected LSH hamsters.

Authors:  J L Schmitz; R F Schell; S D Lovrich; S M Callister; J E Coe
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

4.  Ovalbumin blocking improves sensitivity and specificity of immunoglobulin M immunoblotting for serodiagnosis of patients with erythema migrans.

Authors:  R Lange; H Bocklage; T Schneider; H W Kölmel; J Heesemann; H Karch
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

5.  Novel Borrelia burgdorferi isolates from Ixodes scapularis and Ixodes dentatus ticks feeding on humans.

Authors:  J F Anderson; R A Flavell; L A Magnarelli; S W Barthold; F S Kantor; R Wallich; D H Persing; D Mathiesen; E Fikrig
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

6.  GlpQ: an antigen for serological discrimination between relapsing fever and Lyme borreliosis.

Authors:  T G Schwan; M E Schrumpf; B J Hinnebusch; D E Anderson; M E Konkel
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

7.  Seroprevalence of Borrelia burgdorferi in patients with Behçet's disease.

Authors:  Fatos Onen; Dilek Tuncer; Servet Akar; Merih Birlik; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2003-04-08       Impact factor: 2.631

8.  A flagella-less mutant of Borrelia burgdorferi. Structural, molecular, and in vitro functional characterization.

Authors:  A Sadziene; D D Thomas; V G Bundoc; S C Holt; A G Barbour
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

9.  Relapsing fever and its serological discrimination from Lyme borreliosis.

Authors:  P M Rath; G Rögler; A Schönberg; H D Pohle; F J Fehrenbach
Journal:  Infection       Date:  1992 Sep-Oct       Impact factor: 3.553

10.  Surface immunofluorescence assay for diagnosis of Lyme disease.

Authors:  R Cevenini; V Sambri; F Massaria; R Franchini; A D'Antuono; G Borda; M Negosanti
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.